Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Lexicon Pharmaceuticals Inc
LXRXCurrent price
1.06 USD
-0.02 USD (-1.85%)
Last closed
1.09 USD
Company
www.lexpharma.com
ISIN
US5288723027
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
459 094 848 USD
Yield for 12 month
-7.02 %
1Y
3Y
5Y
10Y
15Y
LXRX
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas. Address: 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.4 USDP/E ratio
–Dividend Yield
–Current Year
+1 204 000 USD
Last Year
+139 000 USD
Current Quarter
+1 647 000 USD
Last Quarter
+1 130 000 USD
Current Year
+565 000 USD
Last Year
-288 000 USD
Current Quarter
+1 342 000 USD
Last Quarter
+955 000 USD
Key Figures LXRX
1 year
3 years
5 years
10 years
EBITDA
-196 474 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.69 %
PEG Ratio
-0.14
Return On Equity TTM
-94.81 %
Wall Street Target Price
5.4 USD
Revenue TTM
3 641 000 USD
Book Value
0.66 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
419.6 %
Dividend Yield
–
Gross Profit TTM
-52 677 000 USD
Earnings per share
-0.78 USD
Diluted Eps TTM
-0.78 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-63.4 %
Profit Margin
–
Dividend Analytics LXRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LXRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:7
Payout Ratio
–
Last Split Date
21.05.2015
Dividend Date
–
Stock Valuation LXRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
68.6408
Price Sales TTM
126.0903
Enterprise Value EBITDA
-2.5763
Price Book MRQ
1.9131
Financials LXRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LXRX
For 52 weeks
1.01 USD
3.73 USD
50 Day MA
1.67 USD
Shares Short Prior Month
26 971 057
200 Day MA
1.91 USD
Short Ratio
11.26
Shares Short
27 650 080
Short Percent
16.97 %
BeatStart